THE INFLUENCE OF CIGARETTE
SMOKE ON ORAL MICROBIOME AND
PERIODONTAL DISEASE.
NAME OF PRESENTER- SHIVANGI KHARBANDA
NAME OF COLLEGE- GURU NANAK INSTITUTE OF
DENTAL SCIENCES AND RESEARCH
THE SMOKING EPIDEMIC
• In India 28.6% of adults- aged 15 and
above are smokers and 3.7% are
occasional users. The prevalence of
tobacco users include people who currently
have either smoked or chewed tobacco.
According to the Global Adult Tobacco
Survey 2, every third adult in rural areas
and every fifth adult in urban areas use
tobacco in some form or the other.
RELATIONSHIP BETWEEN SMOKING AND
PERIODONTAL DISEASE
• Smoking is an independent risk factor for the initiation, extent and severity of
periodontal disease. Additionally, smoking can lower the chances for successful
treatment. Cross-sectional and longitudinal data provide strong support for the
statement that the risk of developing periodontal disease as measured by
clinical attachment loss and alveolar bone loss increases with increased
smoking.
• Smokers also exhibited a decrease in several pro-inflammatory cytokines and
chemokines and certain regulators of T-cells and NK-cells. This reflects the
immunosuppressant effects of smoking which may contribute to an enhanced
susceptibility to periodontitis
Chronic generalized severe
periodontitis in smoker
Chronic generalized severe periodontitis
in smoker
Chronic generalized severe periodontitis in smoker
SMOKING CESSATION
• Counseling and support in
changing behavior
• Using nicotine replacement
products
• Using certain medications
CONCLUSION
• Smoking is well-established risk factor for periodontal disease. It changes the
human microflora, human immune response that leads to destruction of the
supporting tissues of the tooth. Difficult circumstance is a fact that symptoms in
periodontal disease in smokers are increased so it can take years before the
patient seeks help, then it is often too late.
• Treatments in patients with periodontal disease must be focused on
understanding the relationship between genetic and environmental factors. Only
with individual approach we can identify our patients risks and achieve better
results.
REFERENCES
• https://pmc.ncbi.nlm.nih.gov/articles/PMC3633395/
• http://www.medicalnewstoday.com/releases/9702.php
• https://doi.org/10.1016/j.disamonth.2011.03.008
THANK
YOU